Connect with us

Technology

Netech Corporation Releases New State-of-the-Art EEG Simulator: MiniSim EEG 2000

Published

2 years ago

on

Netech Corporation unveils the MiniSim EEG 2000, a cutting-edge, stand-alone EEG simulator, featuring 16 independent signal outputs and a compact, user-friendly design

FARMINGDALE, N.Y., Sept. 5, 2024 /PRNewswire-PRWeb/ — Netech Corporation, a leading innovator and manufacturer of biomedical test instruments, is proud to introduce its newest product, a stand-alone electroencephalogram (EEG) simulator: MiniSim EEG 2000. The hand-held patient simulator is uniquely designed to accurately simulate six different kinds of EEG waveforms: alpha, theta, gamma, delta, and beta brain waves, along with auditory brain response (ABR) waves. MiniSim EEG 2000 is the latest version of one of the company’s best-selling devices, the MiniSim EEG.

We have been serving the biomedical community worldwide since 1987, and we are excited to add MiniSim EEG 2000 to our growing line of patient simulators.

The release of the new EEG simulator is an important development for Netech Corporation as well as the biomedical equipment manufacturers, medical equipment service companies, and the healthcare industry. Here’s why: EEG monitoring devices are essential tools for testing brain activity and identifying brain-related disorders, such as tumors, injuries, stroke, and epilepsy. Ensuring the performance of these monitoring instruments is crucial, which is where MiniSim EEG 2000 excels.

With 16 independent signal outputs, MiniSim EEG 2000 makes it easy for healthcare professionals to confirm the precision of various EEG monitoring devices, including recorders, sleep study monitors, and multi-channel EEG monitoring systems. This, in turn, facilitates the accurate monitoring, diagnosis, and treatment of patients.

“We have been serving the biomedical community worldwide since 1987, and we are excited to add MiniSim EEG 2000 to our growing line of patient simulators,” said Dr. Mohan Das, founder and CEO of Netech Corporation. “This one-of-a-kind instrument highlights our commitment to providing the biomedical community with reliable instruments for the accurate testing and calibration of various patient care equipment.”

Netech Corporation’s revolutionary EEG simulator is also capable of measuring electrocardiogram (ECG) waveforms, along with performance waveforms, such as sine, square and triangle. The unit serves the critical function of helping ensure that the EEG machine being used for patients is in tolerance, which further enhances the value of the company’s patient simulator in the marketplace.

MiniSim EEG 2000 is one of the most advanced and versatile patient simulators on the market today. The device is distinguished by its compact, lightweight, user-friendly design and impressive functionality. MiniSim EEG 2000’s display incorporates a high-contrast 128 X 64 LCD with LED backlighting for easy viewing. Its keypad features soft-touch tactile buttons that offer dedicated key functions. It also has an interactive menu-driven interface that makes it easy for users to select from a variety of functions. In addition, the product has patented EEG cup electrodes that are simple to hook up, and it operates on a rechargeable battery, making it ideal for performance testing all EEG instrumentation.

Patient simulators—also referred to as physiological simulators or vital sign rhythm generators—are invaluable tools for biomedical personnel to accurately evaluate and verify the performance of patient monitoring systems. Essentially, a human patient simulator mimics physiological parameters, such as ECG, arrhythmia waveforms, blood pressure, respiration and temperature. Netech Corporation currently offers four different models of patient simulators, with MiniSim EEG 2000 being the latest creation in this important group of devices.

Netech Corporation has a strong reputation for creating high-quality medical equipment testing products like MiniSim EEG 2000. It is committed to manufacturing state-of-the-art products that satisfy the evolving technological needs and standards of the medical industry. All of the company’s medical testing products—which are made in the United States—are tested, calibrated according to the ISO 9001 quality management system, and comply with National Institute of Standards and Technology (NIST) guidelines. In addition, each of its products comes with a NIST certificate of calibration and is backed by a two-year warranty, excellent customer service, and outstanding technical support.

For more information about Netech Corporation and its new MiniSim EEG 2000 patient simulator, please visit www.netechbiomedical.com or contact Global Sales and Marketing Manager Steven Gonzalez at sales@netechbiomedical.com.

About Netech Corporation

Based in Farmingdale, N.Y., Netech Corporation has been designing and manufacturing innovative biomedical and industrial test equipment since 1987. Its mission is to provide the biomedical industry with the highest quality medical equipment testing instruments and knowledge that fulfill their wants and needs at the right price. As such, Netech Corporation strives to empower the biomedical industry by manufacturing easy-to-use test instruments while leading the way with innovation and ultimate customer satisfaction. The company produces a broad array of affordable biomedical test instruments, including digital pressure/vacuum meters and gauges, patient simulators, electrical safety analyzers, defibrillator analyzers, cardiac output simulators, and EEG simulators.

Media Contact

Steven Gonzalez, Global Sales and Marketing Manager, Netech Corporation, 1 (631) 531-0100 1015, s.gonzalez@netechbiomedical.com, https://www.netechbiomedical.com

View original content to download multimedia:https://www.prweb.com/releases/netech-corporation-releases-new-state-of-the-art-eeg-simulator-minisim-eeg-2000-302239662.html

SOURCE Netech Corporation

Related Topics:
Continue Reading

Technology

MiniTool ShadowMaker 5.0 Introduces Cloud Sync for Google Drive and OneDrive

Published

52 minutes ago

on

October 23, 2026

By

VANCOUVER, BC, Oct. 22, 2026 /PRNewswire/ — MiniTool® Software Limited has announced the release of MiniTool ShadowMaker 5.0, the latest version of its Windows backup and file sync software. The update introduces a new Cloud Sync feature for Google Drive and OneDrive, along with enhancements to the registration and purchase experience, interface refinements, and compatibility fixes.

New Features and Improvements in MiniTool ShadowMaker 5.0

1. Cloud Sync to Google Drive and OneDrive

MiniTool ShadowMaker 5.0 introduces Cloud Sync, allowing users to synchronize files and folders from a Windows computer to Google Drive or OneDrive. Users can choose the files and folders they want to sync and select their preferred cloud storage service as the destination.

The new feature supports one-way synchronization from a local Windows PC to cloud storage, providing an additional way to save copies of important files outside of your computer. Together with MiniTool ShadowMaker’s existing local file sync function, Cloud Sync expands the available destinations for file sync.

2. Streamlined License & Plan Management

The latest update introduces an enhanced register interface that remains easily accessible even after activation. Registered users can now effortlessly review their current plan, explore upgrade options, or update their license key anytime for a smoother user experience.

These refinements are intended to improve usability when users manage their software registration and licensing.

3. Interface Refinements and Compatibility Fixes

MiniTool ShadowMaker 5.0 includes interface improvements and fixes for certain display issues. One notable fix addresses a blurry display issue that could occur on some systems equipped with AMD GPUs.

These changes focus on resolving specific issues and improving the user experience on affected systems.

4. Additional Improvements

Beyond Cloud Sync and the changes outlined above, MiniTool ShadowMaker 5.0 includes additional interface and functionality refinements. Together, these updates further improve the software’s usability while expanding its file synchronization options.

With support for Google Drive and OneDrive, MiniTool ShadowMaker 5.0 provides Windows users with another approach to manage file copies across local and cloud storage. Users who want to synchronize files to cloud storage can download the Free Edition and explore the new capabilities.

About MiniTool ShadowMaker

MiniTool ShadowMaker is a Windows backup and file sync solution designed to help users protect their operating systems and important data. It supports backing up Windows systems, disks, partitions, files, and folders to local drives, external hard drives, shared folders, and other supported locations. Users can select specific items to back up according to their needs.

For users who need to migrate data to another drive, MiniTool ShadowMaker offers a disk cloning feature. The software also supports restoring backed-up data and creating bootable media for system recovery.

By combining backup, file synchronization, disk cloning, and restore capabilities, MiniTool ShadowMaker offers Windows users a set of tools for data protection and system recovery.

About MiniTool® Software Limited

MiniTool Software Limited is a professional software company that develops computer applications. It provides software for partition management, data recovery, data backup and sync, video editing, multimedia conversion, and screen recording for home and business users. The company is committed to developing innovative, reliable, and easy-to-use software that simplifies everyday digital tasks.

View original content to download multimedia:https://www.prnewswire.com/news-releases/minitool-shadowmaker-5-0-introduces-cloud-sync-for-google-drive-and-onedrive-302916663.html

SOURCE MiniTool® Software Limited

Continue Reading

Technology

Rocket Companies to Announce Third Quarter 2026 Results on October 29, 2026

Published

2 hours ago

on

October 22, 2026

By

DETROIT, Oct. 22, 2026 /PRNewswire/ — Rocket Companies, Inc. (NYSE: RKT) (“Rocket Companies” or “the Company”), the Detroit-based homeownership platform, today announced that the Company will issue its third quarter 2026 earnings on October 29, 2026. Leadership will host a conference call to discuss results at 4:30 p.m. ET on that date. A press release detailing the Company’s results will be issued prior to the call.

A live webcast of the event will be available on the “Events & Presentations” section of the Company’s Investor Relations website at ir.rocketcompanies.com. A replay of the webcast will be available on the Investor Relations website following the event.

About Rocket Companies

Founded in 1985, Rocket Companies (NYSE: RKT) is a Detroit-based homeownership platform including mortgage, real estate and personal finance businesses: Rocket Mortgage, Redfin, Rocket Close, Rocket Money and Rocket Loans.

With insights from more than 160 million calls with clients each year, more than 30 petabytes of data and a mission to Help Everyone Home, Rocket Companies is well positioned to be the destination for AI-fueled homeownership.

For more information, please visit the Company’s Corporate website or Investor Relations website.

View original content to download multimedia:https://www.prnewswire.com/news-releases/rocket-companies-to-announce-third-quarter-2026-results-on-october-29-2026-302917496.html

SOURCE Rocket Companies, Inc.

Continue Reading

Technology

Lunai Bioworks Announces Receipt of Nasdaq Determination and Intention to Voluntarily Delist and Deregister

Published

2 hours ago

on

October 22, 2026

By

SACRAMENTO, Calif., Oct. 22, 2026 /PRNewswire/ — Lunai Bioworks Inc. (Nasdaq: LNAI) (the “Company”) announced that on October 21, 2026, it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company no longer complies with Nasdaq Listing Rule 5550(b)(1), which requires minimum stockholders’ equity of $2,500,000. The Company reported a stockholders’ deficit of $(9,024,946) in its Annual Report on Form 10-K for the fiscal year ended June 30, 2026, and does not meet the alternative market value of listed securities or net income standards. Because the Company is subject to a mandatory Hearings Panel Monitor under Nasdaq Listing Rule 5815(d)(4)(B), Nasdaq staff determined to delist the Company’s securities. Trading in the Company’s common stock on Nasdaq is expected to be suspended at the opening of business on October 30, 2026.

The Company will not request a hearing. Rather than contest the staff determination, the Company’s Board of Directors approved on October 22, 2026 the voluntary withdrawal of the Company’s common stock from listing on Nasdaq under Rule 12d2-2(c) under the Securities Exchange Act of 1934, as amended. The Board took this action because of the staff determination and the Company’s financial condition, and concluded that the cost of continued listing and SEC reporting is not justified.

The Company notified Nasdaq of its intention on October 22, 2026. The Company intends to file a Form 25 with the Securities and Exchange Commission (the “SEC”) on or about November 2, 2026, and expects the delisting to become effective on or about November 12, 2026. The Company then intends to file a Form 15 to suspend its SEC reporting obligations, to the extent it is eligible to do so. The Company’s SEC reporting obligations will continue unless and until they are terminated or suspended in accordance with the SEC’s rules.

The Company does not intend to arrange for quotation of its common stock on any over-the-counter market and cannot assure that any trading market for its common stock will exist after trading on Nasdaq is suspended.

Forward-Looking Statements
This press release contains forward-looking statements, including statements regarding the expected suspension of trading, the expected timing of the Form 25 and Form 15 filings, and the expected timing of delisting and deregistration. Actual results may differ materially due to risks and uncertainties, including Nasdaq and SEC procedures and the Company’s financial condition. The Company undertakes no obligation to update these statements, except as required by law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/lunai-bioworks-announces-receipt-of-nasdaq-determination-and-intention-to-voluntarily-delist-and-deregister-302917510.html

SOURCE Lunai Bioworks Inc.

Continue Reading

Trending